Investors

Press releases

2020/05/26

Medivir appoints Yilmaz Mahshid as new CEO

Read more
2020/05/06

FDA grants MIV-818 Orphan Drug Designation for the treatment of hepatocellular carcinoma

Read more
2020/05/05

Resolutions at the Annual General Meeting in Medivir on 5 May 2020

Read more

Presentations

Quarterly report presentations

Events

2020/06/02

Redeye Growth Day

Read more
2020/08/20

Interim Report January - June 2020

Read more
2020/11/10

Interim Report January - September 2020

Read more

Corporate Governance

Medivir Corporate Governance documention.

Annual General Meeting

Documentation from Medivir's Annual General Meetings.